Shenzhen Neptunus Interlong Bio-technique Co Ltd Sustainability Reports
The company is engaged in the research, development, manufacturing, and distribution of medicines, generic drugs, and biological products. It also distributes healthcare products and medical devices primarily within the PRC.
Sector: Manufacturing
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
FIGI: BBG001SCQ387
16 reports from 2010 to 2025
- Shenzhen Neptunus Interlong Bio-technique Co Ltd 2025 Environmental, Social and Governance Report
- Shenzhen Neptunus Interlong Bio-technique Co Ltd 2025 Annual Report
- Shenzhen Neptunus Interlong Bio-technique Co Ltd 2024 Annual Report
- Shenzhen Neptunus Interlong Bio-technique Co Ltd 2024 Environmental, Social and Governance Report
- Shenzhen Neptunus Interlong Bio-technique Co Ltd 2023 Annual Report